The company has received final nod for its abbreviated new drug application (ANDA) for Rasagiline tablets in the strengths of 0.5 mg and 1 mg from the United States Food and Drug Administration (USFDA), Indoco Remedies said in a regulatory filing.from Moneycontrol Business News https://ift.tt/2LR35S2
No comments:
Post a Comment